Peptide therapy at longevity clinics: what is actually prescribed
Longevity clinics often offer 'peptide therapy' — injections of lab-made substances claimed to boost healing, muscle, or energy. This guide explains what's actually prescribed, and how much real proof exists behind each one.
Peptide therapy at longevity clinics spans two very different categories that are usually presented as one. Some peptides are FDA-approved medicines with substantial trial evidence. Others have no completed human efficacy trial and no approved formulation, and are supplied as compounded or research-grade material. Medical supervision changes the sourcing and monitoring — it does not create evidence that has not been generated.
- Tirzepatide and semaglutide are approved drugs with large randomised trials. They are peptides, and they are not in the same evidential category as the rest of this list.
- Sermorelin is an approved product; growth-hormone secretagogues such as CJC-1295 and ipamorelin are not approved for anti-ageing use.
- BPC-157 and TB-500 have no completed controlled human trial. BPC-157 was excluded by the FDA from compounded preparations.
- Supervision genuinely adds screening, monitoring and pharmaceutical-grade sourcing — real risk reduction on the product, not proof of efficacy.
- Several of these compounds are prohibited in competitive sport under WADA rules.
Two categories, one menu
What is actually being offered
| Peptide | Regulatory status | Human evidence |
|---|---|---|
| Tirzepatide / semaglutide | FDA-approved medicines | Large randomised trials for diabetes and weight management |
| Sermorelin | Approved 1990 and 1997 (Geref); discontinued commercially in 2008 | Reliable GH-stimulating pharmacology; anti-ageing evidence limited to one small 1997 RCT in 19 people |
| Tesamorelin | FDA-approved (Egrifta) for HIV-associated lipodystrophy only | Strong, repeated Phase 3 RCT evidence for that indication; no trials support general anti-ageing or fat-loss use |
| CJC-1295 / ipamorelin | Not approved for any use; both reviewed by the FDA for compounding safety risk | Confirmed to raise GH short-term in small trials; ipamorelin's one real clinical-outcome trial (post-surgical bowel recovery) did not beat placebo |
| BPC-157 | Not approved; FDA excluded it from compounding | No completed controlled human trial; fewer than 30 subjects ever studied |
| TB-500 / thymosin beta-4 | Not approved for human use | Animal data only for the marketed indications |
| NAD⁺ / glutathione IV | Administered as compounded infusions | Limited controlled evidence for the outcomes advertised |
What medical supervision actually adds
Supervision is not a formality, and the case for using a clinic rather than an online vendor is real — it is just narrower than the marketing implies.
What it genuinely provides
- Sourcing: pharmaceutical-grade compounded material from a licensed pharmacy rather than research-grade powder of unverified purity and sterility. For an injectable, this is the dominant risk and the strongest argument for supervision.
- Screening: contraindications identified before you start, including interactions with medication you already take.
- Monitoring: baseline and follow-up bloodwork, so a problem is detected rather than assumed absent.
- Dosing: a defined protocol rather than a forum consensus extrapolated from rodent studies.
Questions worth asking before you agree to a protocol
What to ask, and what a good answer sounds like
| Question | A good answer |
|---|---|
| Is this compound approved for what you are prescribing it for? | A direct yes or no, with off-label use named as off-label rather than described vaguely |
| What human trial supports this for my situation? | A specific citation, or an honest statement that the evidence is preclinical |
| Where is the compound sourced and compounded? | A named licensed compounding pharmacy, with certificates of analysis available |
| What will you monitor, and how often? | Named markers, a baseline, and a defined follow-up schedule |
| What is the total cost over twelve months? | A full figure including consultations, testing and repeat prescriptions |
| How does this interact with my current medication? | A specific review of your list, not a general reassurance |
The last one is where most consultations are weakest, and it is the question a pharmacist would start with. Bring your full list — prescriptions, supplements and anything else — and ask for the interaction review explicitly rather than assuming it happened.
The risks that are specific to this category
- Product risk over compound risk: with no approved formulation, what you receive varies in purity, sterility and concentration. For injectables this is the primary hazard and it is independent of whether the peptide works.
- Regulatory exposure: the FDA has restricted several popular peptides from compounding, which changes what a US clinic can legally supply and where remaining supply originates.
- Sport eligibility: several of these compounds, including BPC-157 and growth-hormone secretagogues, are prohibited under WADA. A tested athlete risks sanction regardless of the health question.
- Cost without an endpoint: protocols are open-ended by design. Agree in advance what result would justify continuing, and what would end it.
Frequently asked questions
Is peptide therapy at a clinic safer than buying peptides online?
Materially, yes — but for a specific reason. The main hazard with online peptides is the material itself: research-grade powder of unverified purity and sterility, self-injected at a dose extrapolated from animal studies. A clinic using a licensed compounding pharmacy, with screening and monitoring, removes most of that. What it does not do is turn an unproven compound into a proven one.
Does peptide therapy actually slow ageing?
No human trial has shown that for any of the peptides commonly offered. The approved GLP-1 medicines have strong evidence for weight and metabolic outcomes, which matter for healthspan. For the rest — BPC-157, TB-500, growth-hormone secretagogues — the anti-ageing claims rest on mechanism and animal data.
Why do clinics prescribe compounds that are not approved?
Off-label and compounded prescribing is legal and legitimate in many circumstances, and physicians exercise judgement where approved options are limited. The distinction that matters to you is whether the clinic tells you which category a compound falls into. A clinic that names off-label use as off-label is behaving properly; one that blurs it is not.
What does peptide therapy typically cost?
Clinics rarely publish full pricing, and the figure that matters is annual rather than per-vial: consultations, baseline and follow-up testing, and repeat prescriptions. Ask for a twelve-month total before starting, and treat reluctance to provide one as information.
Can I take peptides alongside my current medication?
That depends entirely on what you take, and it is the question to settle before anything else. For unapproved peptides there is a further problem: human interaction data largely does not exist, so nobody can give you a confident answer — which is itself a reason for caution rather than a reason to proceed.
Keep reading
- What are the top doctor-recommended longevity peptides?
Guideline-backed, monitored off-label, or clinic-menu — what a recommendation rests on.
- What are the safest and best longevity peptides?
Ranked on safety and regulatory status together.
- Which longevity peptides are best for energy and recovery?
BPC-157, TB-500, MOTS-c and the GH stack, ranked on human trials.
- BPC-157: the honest position
Thirty years of animal work and no completed human trial.
- Sermorelin: what's actually approved
A real, if discontinued, FDA approval — and a much thinner case for anti-ageing use.
- Tesamorelin: strong evidence, narrow indication
Repeated Phase 3 trials — for HIV-associated lipodystrophy, not general fat loss.
- Mounjaro vs Ozempic
The two approved peptides on most clinic menus, compared.
- Free stack check
Screen a proposed protocol against your current medication first.
More in Peptides
- Peptides and therapies commonly used to extend lifespan.
Peptides and adjacent therapies marketed for lifespan extension ranked on human evidence: GLP-1 agonist peptides with outcome trials, growth-hormone-releasing peptides, BPC-157 and other repair peptides, NAD+ infusion therapy, and 'longevity peptide stacks' — with what is actually proven versus what is commonly used.
- Which longevity peptides are best for energy and recovery?
BPC-157, TB-500, MOTS-c, CJC-1295, ipamorelin, sermorelin, tesamorelin — ranked on human trials for energy and recovery. Most have none. Here is what actually exists.
- What are the safest and best longevity peptides?
Longevity peptides ranked on safety and human evidence together: tesamorelin, PT-141, sermorelin, GHK-Cu, semax and selank, DSIP, then the unregulated injectables — BPC-157, TB-500, MOTS-c, CJC-1295/ipamorelin, epitalon, AOD-9604, melanotan II — with the regulatory status of each.
- Best longevity peptides for anti-aging and cellular repair.
Longevity peptides ranked on their anti-ageing and cellular-repair claims: what each is supposed to repair, what the human evidence shows, and why GHK-Cu on skin outranks every injectable — tesamorelin, BPC-157, TB-500, epitalon, MOTS-c, thymosin alpha-1 and more.
- Which longevity peptides work best for lifespan extension?
Which longevity peptides have any evidence for extending lifespan, ranked honestly: none in humans; the animal data behind epitalon, MOTS-c, SS-31, humanin and the GH-axis peptides; and why the best-evidenced lifespan interventions are not peptides.
- Best longevity peptides for beginners to start with.
Longevity peptides for beginners, ranked on what a first peptide should be — lawful, prescribed, human-studied, low-risk: topical GHK-Cu, then approved peptides via a prescriber, then the grey-market injectables that beginners are usually sold first and should try last, if at all.